AETHLON MEDIC.NEW DL-001
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, … Read more
Market Cap & Net Worth: AETHLON MEDIC.NEW DL-001 (EJU)
AETHLON MEDIC.NEW DL-001 (STU:EJU) has a market capitalization of $10.81 Million (€10.53 Million) as of March 18, 2026. Listed on the STU stock exchange, this Germany-based company holds position #37736 globally and #4931 in its home market, demonstrating a 700.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AETHLON MEDIC.NEW DL-001's stock price €4.24 by its total outstanding shares 2483530 (2.48 Million).
AETHLON MEDIC.NEW DL-001 Market Cap History: 2015 to 2025
AETHLON MEDIC.NEW DL-001's market capitalization history from 2015 to 2025. Data shows change from $30.59 Million to $10.81 Million (-10.21% CAGR).
AETHLON MEDIC.NEW DL-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AETHLON MEDIC.NEW DL-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.57x
AETHLON MEDIC.NEW DL-001's market cap is 8.57 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $42.83 Million | $650.19K | -$6.37 Million | 65.87x | N/A |
| 2021 | $43.59 Million | $659.10K | -$7.89 Million | 66.14x | N/A |
| 2022 | $6.13 Million | $294.17K | -$10.42 Million | 20.85x | N/A |
| 2023 | $4.92 Million | $574.25K | -$12.03 Million | 8.57x | N/A |
Competitor Companies of EJU by Market Capitalization
Companies near AETHLON MEDIC.NEW DL-001 in the global market cap rankings as of March 18, 2026.
Key companies related to AETHLON MEDIC.NEW DL-001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
AETHLON MEDIC.NEW DL-001 Historical Marketcap From 2015 to 2025
Between 2015 and today, AETHLON MEDIC.NEW DL-001's market cap moved from $30.59 Million to $ 10.81 Million, with a yearly change of -10.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €10.81 Million | +1077.78% |
| 2024 | €917.74K | -81.35% |
| 2023 | €4.92 Million | -19.78% |
| 2022 | €6.13 Million | -85.93% |
| 2021 | €43.59 Million | +1.79% |
| 2020 | €42.83 Million | +107.41% |
| 2019 | €20.65 Million | -95.30% |
| 2018 | €439.75 Million | +30.53% |
| 2017 | €336.88 Million | +1001.25% |
| 2016 | €30.59 Million | 0.00% |
| 2015 | €30.59 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AETHLON MEDIC.NEW DL-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.81 Million USD |
| MoneyControl | $10.81 Million USD |
| MarketWatch | $10.81 Million USD |
| marketcap.company | $10.81 Million USD |
| Reuters | $10.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.